Global health & development

Debate around health systems often focuses on lives saved by new or improved medicines and fails to consider the long-term development of scientific research capacity in low and middle income countries, and how this affects the health of a country’s population and its economic growth. A recognition that health, education and industrial policy are interlinked is at the core of Innogen’s approach.

Projects

Foresight project: Detection and Identification of Infectious Diseases
-

Innogen retreat 2019

10 October 2019

This year's annual meeting took place 3-4 October in Edinburgh and it brought together researchers from the Open University and the University of Edinburgh as well as colleagues from the Open University Scotland. 

Drug manufacturing in Africa e-book hit

18 June 2020

A free e-book featuring innogen's research into drug manufacturing in Africa has become one of Palgrave Macmillan’s top five open access downloads of all time.

Joyce Tait delivers keynote presentation at Bloomsbury SET conference

18 March 2021

Innogen co-director Joyce Tait gave a keynote presentation at the virtual Bloomsbury SET conference focused on infectious diseases and antimicrobial resistance. Her talk in the first session of the conference: “Interdisciplinary knowledge exchange to tackle global health challenges” highlighted some of the Innogen’s work on regulatory adaptation to support the development of new antimicrobial drugs and rapid diagnostics.

Extractive economic and political institutions in African countries have locked-in the pharmaceutical sector into industrial under-development.

8 March 2023

In a new article published in Frontiers in Research Metrics and Analytics, Geoff Banda analyses the impact of extractive economic and political institutions on the industrial development of the African pharmaceutical sector.